PathMD

PathMD

Search
Skip to content
  • Immunohistochemistry
  • WHO Heme Classification
  • CK7 / CK20 Tables
  • Organ Systems
  • About
Organ Systems, Breast

Breast – Tubular Carcinoma

October 24, 2017 peferguson
General
  • Low-grade (well differentiated, extensive tubule formation)
  • Morphological overlap with a benign sclerosing lesion (e.g. radial scar)
  • Use myoepithelial marker(s) (e.g. SMM-HC, calponin, p63) to differentiate from a benign process.

Photomicrograph
Breast - Tubular Carcinoma
Breast – Tubular Carcinoma
Breast - Tubular Carcinoma
Breast – Tubular Carcinoma
Breast - Tubular Carcinoma
Breast – Tubular Carcinoma

Share this:

  • Twitter
  • WhatsApp
  • Facebook
  • Email
  • Print
  • LinkedIn

Related

Post navigation

Previous PostMucinous (Colloid) CarcinomaNext PostCalcitonin

PathMD E-Mail Signup

Poll

Which of the following IHC markers do you most commonly use to identify breast myoepithelial cells?
Results

Search PathMD

Important Links

Cancer Protocols

Am. Board of Path. 

PathMD Blog

PathMD
Proudly powered by WordPress
 

Loading Comments...